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1. INTRODUCTION 
 
1.1. Cartilage tissue biology 
 
 Cartilage is a form of tough and flexible connective tissue composed of sparsely 
distributed chondrocytes embedded within a dense extracellular matrix (ECM) 
characterized by high amount of glycosaminoglycans and proteoglycans which interact 
with collagen and elastic fibers. Chondrocytes are essential for production and 
maintenance of ECM components and are located in the matrix cavities called lacunae 
(Mescher, 2013).  
 Cartilage is avascular and receives nutrients solely by diffusion from capillaries in 
adjacent connective tissue (perichondrium) or, in the case of articular cartilage, from 
synovial fluid (Mescher, 2013; Horvai, 2011). Large blood vessels can traverse cartilage 
in order to supply other tissues, but these vessels release few nutrients to the cartilage. 
Cartilage also lacks lymphatic vessels and nerves. 
 The firm structure of ECM contributes to its resiliency which allows cartilage to 
bear mechanical stresses without permanent distortion. It serves as shock-adsorbing and 
sliding surface within joints and facilitates bone movements. In some parts of the body, 
cartilage supports soft tissues like those in the respiratory tract, nose and ears. It also 
plays important role in development and growth of long bones, both before and after birth 
(Mescher, 2013).  
 Based on differences in matrix composition, location in the body and functional 
requirements, three main types of cartilage can be distinguished: hyaline cartilage, elastic 
cartilage and fibrocartilage.  
 Hyaline cartilage (gr. hyalos = glassy) is the predominant type in the human body. 
In adults, hyaline cartilage is located in the articular surfaces of movable joints, the ventral 
aspects of the ribs, in the walls of larger respiratory passages (nose, larynx, trachea, 
bronchi). It also exists in the epiphyseal plates (growth plates) of long bones allowing 
longitudinal bone growth. During skeletal development, it forms temporary skeleton that 
is gradually replaced by bone. 
 Elastic cartilage is present in the auricle of the ear, the walls of the external 
auditory canals, the eustachian tube, the epiglottis and parts of the larynx. 
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 Fibrocartilage comes in various forms, but it is mostly composed of hyaline 
cartilage and dense connective tissue with gradual transitions between these tissues. It 
exists in invertebral discs, the symphysis pubis and in the junctions between large 
tendons and articular cartilage in large joints (Meyer et al, 2006). 
 
1.2. Articular cartilage  
 
 Articular cartilage is a form of hyaline cartilage, located in the diarthrodial 
(synovial) joints and best characterized of cartilage subtypes (Horvai, 2011). Because of 
its smooth and lubricated surface, articular cartilage has impressive load-bearing capacity 
and provides almost frictionless articulation of joint surfaces. Moreover, articular 
cartilage distributes the loads over a larger contact area which minimizes contact 
stresses. It is a tissue only few millimeter thick, but with excellent wear characteristics. 
These properties makes it ideally suited for placement in joints such as the knee and hip. 
Mechanical and structural capacity of articular cartilage is owed to its unique and complex 
architecture (Fox et al, 2009; Ergelett et al, 2008; Al-Rubeai & Melero-Martin, 2007). 
 
1.2.1. Structure and composition 
 
1.2.1.1. Composition of articular cartilage 
 
 Articular cartilage is not a homogeneous tissue. It has a highly organized structure 
with biphasic nature, consisting of fluid (mostly water) and a solid, porous-permeable, 
dense ECM which contributes to its biomechanical function (Cohen et al, 1998). Like other 
types of cartilage, articular cartilage lacks blood vessels, lymphatic vessels, nerves, 
inflammatory cells and fibroblasts (Horvai, 2011). 
 
  Normal articular cartilage is composed of only single cell type, the chondrocyte.   
They originate from immature mesenchymal cells that differentiate from somatic or 
visceral mesoderm during early development and occupy about 2% of the total volume of 
articular cartilage (Horvai, 2011).  
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 Chondrocytes may appear in the groups of up to eight cells called isogenous 
aggregates, emerged from the mitotic divisions of a single chondrocyte. As chondrocytes 
start to produce and secrete ECM components, they are pushed apart from aggregates and 
become separated each in its own surrounding space (lacuna) (Fig 1) (Mescher, 2013). 
This microenvironment traps cells within their own matrix which prevents chondrocyte 
migration or formation of direct cell-to-cell contacts (Fox et al, 2009). 
 
 
Figure 1. Location of articular chondrocytes. Each cell resides in lacuna surrounded by 
extensive ECM                                                                                                                                           
(downloaded from: www.studyblue.com). 
 
 
 Depending on the location within cartilage, chondrocytes can exhibit different 
sizes and shapes. In the deeper zones, they are normally rounded or polygonal, while 
those at the periphery may be flattened or discoid with the long axis parallel to the surface 
of the cartilage (Mescher, 2013; Archer & Francis-West, 2003). 
 Structurally, chondrocytes show intracellular features characteristic for 
metabolically active cells responsible for production and maintenance of cartilage ECM 
(Fig. 2) (Fox et al, 2009; Archer & Francis-West, 2003). They produce structural 
macromolecules essential for tissue formation (collagens and proteoglycans), but also 
make variety of metalloproteinases (collagenases, gelatinases, aggrecanases) which are 
responsible for tissue turnover (Roughley, 2002). 
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Figure 2. Electron micrograph of articular chondrocyte. The cell is typically rounded with 
prominent Golgi apparatus and rER which is associated with the production and secretion of 
cartilage ECM components (adapted from Archer & Francis-West, 2003). 
 
 Beside ECM production, chondrocytes have important function in growth, 
especially that associated epiphyseal plates in the long bones. It is achieved through three 
basic mechanisms: cell proliferation, matrix secretion and increased cell volume that 
occurs  during hypertrophy (terminal differentiation) (Archer & Francis-West, 2003).  
 Since articular cartilage is not vascularized, nutrient and metabolite exchange 
occurs through diffusion from synovial fluid. Therefore, the metabolism of chondrocytes 
is adapted to low oxygen tension which ranges from 10% at the surface to <1% in the 
deeper layers. As a result, chondrocytes do not contain abundant mitochondria and 
produce energy mostly by glycolysis (Bhosale & Richardson, 2008; Archer & Francis-
West, 2003). 
 
 Cartilage ECM is composed mostly of water, collagen, proteoglycans and other 
noncollagenous proteins and glycoproteins in lesser amounts. It protects chondrocytes 
from mechanical damage and has an important role in maintaining chondrocyte 
phenotype and shape. Components like nutrients, substrates, synthesized and degraded 
molecules, metabolic waste, cytokines and growth factors are stored or pass through the 
matrix (Gaut & Sugaya, 2015). 
 The most abundant component of cartilage ECM is water which makes 80% of 
cartilage wet weight (Fox et al, 2009). The high water content is owed to proteoglycans 
which attract water due to their negative charge. It is unevenly distributed throughout 
cartilage with the highest concentration on the surface. The constant movement and 
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diffusion of water through cartilage matrix is important for transport and delivery of 
nutrients to chondrocytes (Horvai, 2011). 
 Collagen represents 60% of the dry weight of cartilage which makes it the most 
abundant structural macromolecule in ECM (Fox et al, 2009). Different types of collagen 
are present in the cartilage and can be divided into fibril-forming and non-fibril-forming 
collagens (Hu & Athanasiou, 2010). Types II, IX and XI form the core fibrillar network 
responsible for cartilage’s resilience and ability to endure sheer forces (Ergelett et al, 
2008; Eyre, 2002). Other types of collagen (I, III, IV, V, VI, X, XII, XIV) do not form fibers, 
but contribute to ECM structure by enabling formation and stabilizing the type II collagen 
fibril network. Type II collagen is the most abundant type of collagen in hyaline articular 
cartilage and represents 90-95% of collagen present in the ECM (Fox et al, 2009). It 
supports chondrocyte adhesion and induces phenotypic differentiation of cells (Meyer et 
al, 2006). The entire collagen fibrillar network is stabilized by 100 000 Da protein 
cartilage oligomeric matrix protein (COMP) (Hu & Athanasiou, 2010). 
 Proteoglycans are heavily glycosylated proteins consisted of a protein core with 
covalently attached chains of glycosaminoglycans (GAG). Glycosaminoglycans are long 
non-branching polysaccharides built of repeating disaccharide units. The presence of 
sulphate (SO42-) and carboxylate (COO-) ionic groups gives an overall negative charge to 
GAG macromolecules. Keratan sulfate and chondroitin sulfate are the most abundant 
types of GAG in articular cartilage (Hu & Athanasiou, 2010). Among proteoglycans the 
most important are aggrecan, decorin, biglycan and fibromodulin. The most abundant and 
largest in size is aggrecan (Fox et al, 2009). It is composed of a large core protein with 
attached side chains of keratan sulfate and chondroitin sulfate.  It occupies interfibrillar 
space of cartilage ECM and aggregates with large, unbranched polysaccharide hyaluronan 
via link proteins (Fig 3). Negatively charged GAG side chains repel each other which gives 
aggrecan a shape similar to a bottle brush. The overall negative charge of aggrecan 
attracts positively charged ions and molecules and creates a positive osmotic pressure 
which causes a matrix to swell. The swelling force is balanced by collagen fibers. This 
process gives cartilage its biomechanical properties and allows it to resist compressive 
loads (Bhosale & Richardson, 2008). Aggrecan synthesis is an important hallmark of 
chondrogenesis and represents a key marker in research of its molecular mechanisms 
(Knudson & Knudson, 2001). 
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Figure 3. A schematic representation of structure and interaction of key molecular 
components of cartilage ECM: collagen type II fibrils and proteoglycans linked to hyaluronic 
acid (adapted from Mescher, 2013) 
 
1.2.1.2. Structure of articular cartilage 
 
 Based on the differences in cell shape, size and activity, as well as distribution and 
arrangement of main ECM components, articular cartilage can be divided in four distinct 
structural zones: superficial (tangential), middle (transitional), deep and calcified 
cartilage (Fig 4)(Duarte Campos et al, 2012). 
 The superficial zone occupies 10-20% of the total thickness of articular cartilage. 
This zone contains high number of ellipsoid-shaped, flattened chondrocytes with the long 
axis parallel to the surface. Matrix in this zone is characterized by high collagen 
concentration (~86% dry weight) and low proteoglycan concentration (~15% dry 
weight) (Hu & Athanasiou, 2010). Collagen fibrils (mainly composed of collagen type II 
and IX) are aligned parallel to the surface of cartilage. Fibronectin and water 
concentration are highest in this zone (Buckwalter et al, 2005). Superficial chondrocytes 
and synoviocytes produce lubricating components, mainly glycoprotein lubricin and 
superficial zone protein which form a protective layer on the surface of cartilage. Its main 
function is reduction of friction and wear (Mollenhauer, 2008; Rhee et al, 2005). 
 The middle zone makes 40-60% of the total thickness of articular cartilage. This 
layer contains randomly organized collagen fibrils and lower number of rounded 
chondrocytes. Water and collagen contents in this zone are lower compared to superficial 
zone. Proteoglycan content is the highest in this layer (~25% dry weight) (Fox et al, 
2009). 
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 The deep zone makes 30% of total thickness of articular cartilage. This layer is 
characterized by thick, perpendicularly arranged collagen fibrils, high proteoglycan and 
low water content. These properties give this layer the greatest resistance to compressive 
forces (Fox et al, 2009). Tidemark is a calcified region that separates deep from calcified 
zone. 
 The calcified zone serves as a transition between articular cartilage and underlying 
subchondral bone. It contains minimal amounts of collagen and water. Chondrocytes are 
smaller in volume and embedded in a mineralized matrix.  They show minimal metabolic 
activity and express hypertrophic phenotype characterized by synthesis of collagen type 
X (Bhosale & Richardson, 2008). 
 
 
Figure 4. Zonal organization of articular cartilage. Zones differ in number and shape of 
chondrocytes as well as the organization, density and thickness of collagen fibrils 
 (from Doulabi et al, 2014) 
 
 
1.2.2. Damage and repair  
 
 Articular cartilage damage can be the result of degenerative joint diseases, most 
commonly osteoarthritis, different genetic or metabolic conditions and trauma (Hunziker, 
2001). Articular cartilage lesions generally do not heal or heal only partially under certain 
biologic conditions. It has been known for a long time that this tissue has weak or no 
capacity to repair itself. Even in 1743 famous Scottish anatomist and physician William 
Hunter reported: “Ulcerated cartilage is a troublesome thing…once destroyed it is not 
repaired.” (Chiang & Jiang, 2009). The poor ability of articular cartilage for spontaneous 
self-repair is the result of low cellularity of the tissue, immobility of chondrocytes, limited 
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ability of mature chondrocytes for proliferation, avascularity of the tissue and, 
consequently, inaccessibility of undifferentiated progenitor cells that can promote repair 
(Temenoff & Mikos, 2001; Ghivizzani et al, 2000). 
 The manner in which articular cartilage responds to the traumatic injury depends 
on the type of the injury. Traumatic injuries fall into three categories: microdamage, 
chondral lesions and osteochondral lesions (Frenkel & Di Cesare, 1999). Microdamage is 
a type of injury that includes loss of proteoglycans or other ECM components and is not 
visible on the articular surface. Chondrocytes recognize these changes and respond by 
increased production of ECM components. As long as produced ECM is greater or equal to 
the amount of lost ECM, homeostasis of tissue is preserved and tissue can recover. 
Otherwise, chondrocytes are no longer protected by matrix and tissue degenerates. The 
result of these focal mechanical disruptions are chondral injuries like chondral fissures 
and flaps (Hu & Athanasiou, 2010). However, because chondrocytes are unable to produce 
large amounts of ECM, in the case of accumulated microdamage, originally small focal 
defects usually progress and finally result in destruction of the entire thickness of 
articular cartilage layer. These so called chondral lesions do not heal spontaneously.  
 On the other hand, osteochondral or full thickness defects which penetrate to 
subchondral bone and bone marrow spaces do have a potential for intrinsic repair 
(Getgood et al, 2009). This kind of defect causes lesions of bone blood vessels. Soon after 
injury, blood from damaged blood vessels forms a hematoma which fills the injury site. 
Fibrin forms inside the blood clot and platelets bind to collagen fibrillar network.  
Platelets release many bioactive factors including platelet-derived growth factor (PDGF) 
and transforming growth factor beta (TGF-β) (Buckwalter, 1998). Beside platelets, large 
quantities of growth factors are also released from the bone like TGF-β, PDGF, bone 
morphogenic proteins (BMPs), insulin like growth factors I and II (IGF-I,-II). These growth 
factors play a key role in initiation of repair of osteochondral defects by stimulating 
vascular invasion and migration of stem cells on the site of injury. Different kinds of stem 
cells are involved in the repair process originating from bone marrow spaces, adipose 
tissue, vascular and perivascular tissue, bone and synovium (Buckwalter, 1998; Hunziker, 
2001). Recruited stem cells differentiate in chondrocyte-like cells which produce matrix 
of proteoglycans, collagen type II and I. However, matrix degenerates and formed tissue 
is gradually replaced with more fibrous tissue. Also a shift in collagen production occurs, 
from collagen type II to predominantly type I (Frenkel & Di Cesare, 1999). At the end of 
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repair process, formed tissue resembles a mixture of hyaline cartilage and fibrocartilage 
and shows different characteristics compared to native articular cartilage. It lacks 
structural organization, contains higher amount of collagen type I, shows inferior 
biomechanical properties and usually degrades with time (Steinert et al, 2007; Redman 
et al, 2005). For these reasons, osteochondral lesions rarely heal completely and often 
lead to occurrence of osteoarthritis. 
 Except for the depth of cartilage damage, other important factor in the repair 
response is the size of the defect. Study in horses has showed that only those defects 
smaller than 3 mm in diameter can repair completely after 9 months (Convery et al, 1972; 
Hurtig et al, 1988). Other important factors are also age, obesity and practicing certain 
kind of sport where is higher probability for traumatic injuries (Bhosale & Richardson, 
2008; Mithoefer et al, 2008). 
 The most common degenerative disease of synovial joints affecting millions of 
people is osteoarthritis (OA). It is characterized by progressive degeneration of articular 
cartilage, remodeling of subchondral bone, formation of bone outgrowths or osteophytes 
and synovitis (Lories & Luiten, 2012). These changes can lead to symptoms such as pain, 
stiffnes and loss of joint function. It usually affects joints of hand, knee, foot and hip 
(Wieland et al, 2005). Osteoarthritis is considered to be a multifactorial disease to which 
both genetic and acquired factors contribute. Ageing increases the risk for OA by 
compromising the balance between anabolic and catabolic processes in the cartilage 
tissue (Martin & Buckwalter, 2002). Obesity and history of joint trauma are also proven 
to be important risk factors for OA (Wieland et al 2005). In some families with cases of 
OA, an inheritance of mutant allele for type II procollagen gene (COL2A1) has been 
identified (Frenkel & Di Cesare, 1999).  
 
1.2.3. Treatment options 
 
 Highly organized structure and limited repair capacity of articular cartilage make 
it extremely challenging to treat cartilage injuries medically.  For the past three centuries 
physicians and scientists have tried to find effective therapies and procedures in order to 
accomplish repair or regeneration of articular cartilage after degeneration or traumatic 
damage. These methods fall into three categories or approaches (Steinert et al, 2007). 
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 The first approach is based on mechanical penetration of subchondral bone by 
abrasion or drilling. It causes bleeding and induces natural repair response through stem 
cell migration and differentiation. These techniques include microfracture, abrasion 
arthroplasty and Pridie drilling (Redman et al, 2005; Bhosale & Richardson, 2008). 
Microfracture is cheap, easy to perform, minimally invasive and thus mostly used 
technique. However, the final outcome is the formation of fibrocartilagenous tissue with 
different biomechanical properties (Getgood et al, 2009).   
 The second approach includes transplantation of pieces of tissue in the place of a 
full thickness cartilage defect. Damage site can be filled with small plugs from a less weight 
bearing region of the joint (autografts) and the method is called mosaicplasty, or with a 
full allograft mostly derived from cadaveric donors (Redman et al, 2005). The main 
limitation of mosaicplasty is a small amount of cartilage in the body available for 
transplantation to other sites. Important issues that need to be questioned are the effects 
of damage to the donor site as well as the ability of autograft from a less weight bearing 
region to withstand the forces at the joint surface (Temenoff & Mikos, 2001). Allograft 
transplantations proved to be a successful treatment, with 95% survival rate at five years 
(O’Driscoll, 1998). However, there have been cases of immunologic response to fresh 
allografts after transplantation. Beside osteochondral grafts, perichondrium and 
periosteum grafts are also used (Redman et al, 2005). 
 The third approach is based on transplantation of cells. Since it has been performed 
for the first time in 1987, autologous chondrocyte transplantation (ACT) or autologous 
chondrocyte implantation (ACI) has proved to be promising. The entire procedure of ACI 
in humans was firstly described by Brittberg et al (1994). The procedure involves 
isolation of patient’s own chondrocytes from small slices of cartilage. The extracellular 
matrix is removed by enzymatic digestion and cells are then expanded in a monolayer 
culture. Perisoteal flap is sutured over the defect and cultured autologous chondrocytes 
are injected under the flap. An improved and modified version of this method is matrix- 
induced autologous chondrocyte implantation (MACI) where chondrocytes are combined 
with matrix made of resorbable biomaterials. Biomaterials enhance proliferation and 
differentiation of cells (Fig. 5) (Marlovits et al, 2006). 
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Figure 5. Basic principles and comparison of autologous chondrocyte implantation (ACI) 
and matrix-induced chondrocyte implantation (MACI) methods 
(from Ducheyne et al, 2012) 
 
1.3. Cartilage tissue engineering 
 
 Despite the availability of various cartilage defect treatment options, none of them 
proved to be entirely effective in restoration or regeneration of hyaline cartilage tissue. 
The final outcome is mostly the formation of fibrocartilagenous tissue characterized by 
higher amount of collagen type I, different structure and biomechanical properties 
inferior to native articular cartilage. Growing problems of obesity and ageing of overall 
population will lead to dramatic increase in cases of osteoarthritis and other cartilage 
pathologies in general. Therefore, cartilage diseases and defects are becoming a major 
socioeconomic and medical problem (Chung & Burdick, 2008). 
 Tissue engineering (TE) is an evolving field that has a potential to revolutionize 
medicine and provide permanent solutions to tissue damage and tissue loss.  The goal of 
TE is to provide living biological/physiological substitutes that could replace tissue loss 
due to diseases, congenital abnormalities or trauma. This substitute should be able to 
perform similar biological functions and have similar structural and morphological 
features as native tissue (Nesic et al, 2006; Hardingham, 2002). Tissue engineering is a 
multidisciplinary field that combines knowledge from cell and molecular biology, material 
science, engineering and medicine (Vunjak-Novakovic, 2006). It is based on manipulation 
of several key components and their combinations: i) cells which produce desired tissue, 
ii) scaffolds which promote proliferation and differentiation of cells by providing a three-
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dimensional environment, iii) biochemical and physical factors which provide signals that 
direct cell’s development towards a certain phenotype (Gomes & Reis, 2004). To date, 
great advances have been achieved in the field of TE of different tissues and organs (Atala, 
2009; Amiel et al, 2006; De Filippo et al, 2004; Vesely, 2005; Kulig & Vacanti, 2004). 
  Cartilage TE is not an entirely new approach. Above mentioned methods ACI and 
MACI can be considered as forerunners of cartilage TE. The main goal of cartilage TE is to 
produce cartilage tissue with similar structure and properties ex vivo which can be then 
implanted on the site of the defect in the joint. The implant should be able to provide 
natural repair and with time become integrated with the patient’s tissue (Hardingham, 
2002). However, to date, the properties and structure of native articular cartilage have 
not been entirely mimicked by TE methods. Therefore the main challenge of cartilage TE 
is to determine a right combination of appropriate cell type and matrix scaffold together 
with biochemical and physical factors which will ultimately result in articular cartilage 
formation.  This requires intensive research that deepen our understanding of natural 
process of chondrogenesis and articular cartilage biology. These findings enable constant 
improvements and optimization of cartilage TE components. 
 
1.3.1. Cell source 
 
 One of the basic challenges of cartilage TE is to identify an ideal cell source. It 
should be easy to isolate, capable of expansion and production of cartilage-specific ECM 
molecules (collagen type II and aggrecan) (Chung & Burdick, 2008). Chondrocytes are the 
most obvious choice since they are found in natural cartilage and have been extensively 
researched for cartilage repair (Kisiday et al, 2002). Other potential source are fibroblasts 
which can be easily isolated, expanded and directed toward chondrogenic phenotype 
(Nicoll et al, 2001). Recently, mesenchymal stem cells have been considered as potential 
cell source for cartilage TE. These cells can be isolated from many different tissues and 
show great capacity for differentiation in vitro. Additionally, all these cell types can be 
modified genetically to induce or enhance chondrogenesis (Madry et al, 2005). 
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1.3.1.1. Chondrocytes 
 
 Chondrocytes have been widely used for the purposes of cartilage TE. Adult 
chondrocytes have been isolated from various sources like articular cartilage, nasal 
septum, ribs or ear cartilage and used for TE (Bhardwaj et al, 2015). Since they comprise 
only a small percentage of articular cartilage, prior to use a necessary step is their 
expansion in monolayer cultures. However, such culture causes these cells to lose their 
specific phenotype and this phenomenon is described in the literature as chondrocyte 
dedifferentiation (Freyria & Mallein-Gerin, 2012). This process is characterized by 
decreased synthesis of proteoglycans and collagen type II expression, increased 
expression of collagen type I and change to more fibroblast-like phenotype. Changes in 
expression of several other genes also accompany this process (integrins, growth factors, 
matrix modulators, different kinases) (Chung & Burdick, 2008). Darling et al (2005) 
showed changes in articular chondrocyte gene expression as early as the first passage. 
The use of passaged, dedifferentiated chondrocytes for cartilage TE can lead to 
compromised tissue quality with decreased biomechanical properties. Three- 
dimensional cultures like alginate, agarose beads and fibrin glue may preserve 
chondrocyte phenotype (Bhardwaj et al, 2015). Additionally, a variety of methods have 
been employed to redifferentiate passaged chondrocytes: 3D scaffolds, bioreactors, 
reduced oxygen tension and addition of different growth factors (TGFβ, fibroblast growth 
factor (FGF) and IGF) (Chung & Burdick, 2008). 
 
1.3.1.2. Mesenchymal stem cells 
 
 Mesenchymal stem cells (MSCs) are self-renewing pluripotent cells that have a 
potential to differentiate into chondrocytes, adipocytes, osteoblasts, fibroblasts and other 
tissues of mesenchymal origin (Fig 6). They reside in many tissues within the adult 
organism. Multipotency and great proliferation capacity make them a valuable cell source 
for TE in general (Bhardwaj et al, 2015). The chondrogenic potential of stem cells from 
various tissues has been investigated (muscle, periosteum, synovial membrane, adipose 
tissue), but those originating from bone marrow seems to be the most used for cartilage 
TE (Freyria & Mallein-Gerin, 2012). Mesenchymal stem cells are rare in bone marrow, 
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representing approximately 1 in 10,000 nucleated cells (Chamberlain et al, 2007). For 
their application in cartilage TE, it is necessary to amplify them in vitro to obtain sufficient 
cell number for laboratory and clinical purposes. Afterwards, the expanded bone marrow 
stem cells (BMSCs) need to be exposed to specific chemical, physical and/or mechanical 
factors that will promote chondrogenic differentiation (Freyria & Mallein-Gerin, 2012). 
Crucial factors and conditions that serve as chondrogenic signals and promote 
chondrogenesis are discussed in the chapter 1.3.3. 
 
 
Figure 6. The multilineage differentiation potential of mesenchymal stem cells (MSCs). 
Under appropriate conditions MSCs can differentiate into different tissues: adipose tissue, bone, 
tendon (upper row, from left to right); muscle, cartilage, stroma (lower row, from left to right) 
(from Chen & Tuan, 2008). 
 
1.3.2. Scaffolds 
 
 Scaffolds represent one of the key components of TE approach. Scaffold materials 
facilitate the attachment, proliferation, differentiation of embedded cells and function as 
a template which controls the geometry of newly formed tissue (Moutos & Guilak, 2008). 
The choice of scaffold material depends on the type of tissue that is being engineered, i.e. 
different tissues have different requirements for success, which has led to development 
of various materials with unique characteristics. However, each scaffold that is being used 
needs to be biocompatible, provoking no inflammation or immune reaction; 
biodegradable, to enable newly formed tissue to replace the scaffold; porous, to enable 
cell migration and nutrient exchange and biomimetic, to mimic structure and function of 
native tissue (Smith & Grande, 2015). 
 To date, a wide range of natural and synthetic materials have been investigated as 
scaffolds in cartilage TE. Natural polymers that have been explored as bioactive scaffolds 
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for cartilage TE include collagen, silk, fibrin, alginate, agarose, gelatin, chitosan, hyaluronic 
acid (HA) and cellulose (Bhardwaj et al, 2015). Natural polymers are similar to ECM and 
often interact with cells via surface receptors and affect cell function. However, due to this 
interaction, they can stimulate an immune system response. Additionally, they may be 
inferior mechanically and subject to enzymatic host degradation (Chung & Burdick, 
2008). On the other hand, chemistry and properties of synthetic polymers are controllable 
and reproducible. Different chemical and physical parameters of a synthetic polymer can 
be modified to alter their mechanical and degradation characteristics (Drury & Mooney, 
2003). Synthetic polymers that are currently being explored for application in cartilage 
TE include poly (glycolic acid) (PGA), poly (lactic) acid (PLA), poly (ethylene-glycol) 
(PEG), polyurethanes, etc. (Bhardwaj et al, 2015). Drawbacks to synthetic scaffolds 
include risk of rejection and inflammatory response as well as forming of degradation 
byproducts that may be toxic and negatively influence on cells and surrounding tissue 
(Gaut & Sugaya, 2015).  
 Since recently, composite scaffolds have been developed in order to overcome 
certain disadvantages of single-phase biomaterials. They are mostly composed of a 
mixture of natural and synthetic polymers and allow the creation of more complex 
geometries and better functional properties more representative to articular cartilage 
(Gaut & Sugaya, 2015). 
 
1.3.2.1. Peptide hydrogel scaffold 
 
 Hydrogels are materials consisted of a water-swollen, three-dimensional (3D) 
network which permits attachment of molecules and cells. These scaffolds serve as a 
substitute for natural ECM to organize cells into 3D architecture and to present stimuli 
which direct the growth and a formation of a desired tissue. Currently, they are being 
widely used for the purposes of TE (Seow & Hauser, 2014).  
 Hydrogels can be consisted of natural or synthetic materials which are able to form 
a gel after physical, ionic or covalent crosslinking (Liu et al, 2010).  Protein-based scaffolds 
are biodegradable materials with high water content. They provide temporary support 
for cell growth and maintenance as they facilitate the exchange of nutrients, gases, 
metabolic waste and cell signaling molecules (Amini & Nair, 2012). 
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 In the early 1990s ionic self-complimentary self-assembling peptides were 
discovered (Koutsopoulos, 2009). These peptides consist of alternating hydrophilic and 
hydrophobic amino acids. When dissolved in deionized water, self-assembling peptides 
form stable β-sheet structures. Exposure to electrolyte solution initiates β-sheet assembly 
into nanofibers with diameters of 10-20 nm. These nanofibers further organize to form 
highly hydrated hydrogels (Kisiday et al, 2002; Spiller et al, 2011). Peptide hydrogels do 
not use harmful materials to initiate solution-gel transformation (eg. toxic cross-linkers) 
and degradation products are amino acids which can be metabolized. They are 
biodegradable, non-immunogenic and injectable which allows their application in a 
minimally invasive manner. Additionally, peptide sequences can be designed for specific 
cell-matrix interactions that influence cell differentiation and tissue formation (Kisiday et 
al, 2002). Member of this family is the peptide RADA 16 with a repeating sequence [Ac-
(RADA)4-COHN2] or acetyl-(Arg-Ala-Asp-Ala)4)-CONH2 that facilitates hydrogel formation 
with >99% water content in the presence of salts (Koutsopoulos, 2009). This peptide 
contains a RAD motif, similar to integrin receptor binding site RGD. It is not known if the 
RAD repeats behave in the same manner to RGD motifs. Their properties as cell adhesion 
molecules are being investigated in different cell types (Bokhari et al, 2005). Different cell 
types embedded in peptide hydrogel RADA as a 3D scaffold showed successful 
differentiation, migration and production of their own ECM. There are reports of RADA 
application in cartilage, bone and brain TE (Kisiday et al, 2002; Spiller et al, 2011; Cheng 
et al, 2013). Another important potential application of peptide hydrogels is for controlled 
release of small molecules which can be entrapped within. Peptide hydrogels are 
biocompatible which means that they slowly degrade and release entrapped molecules. 
Controlled release of signal molecules like growth factors or drugs can be useful in TE for 
controlled delivery of inductive signals that promote differentiation and tissue formation 
(Koutsopoulos, 2009). 
  
1.3.3. Chondrogenic signals 
 
  Third component of tissue engineering are different stimulating factors able to 
induce, accelerate and enhance cartilage tissue formation. First group are different 
growth factors and other additives that affect cellular differentiation and cartilage tissue 
formation. Growth factors like TGF-β, FGF, BMP and IGF together with other soluble 
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factors like insulin have been explored for their effects on cartilage TE. Among these 
molecules, TGF-β superfamily of cytokines play a major role in cartilage tissue formation 
(Chung & Burdick, 2008). The TGF-β superfamily is comprised of more than forty 
members, including the BMPs. They are involved in the processes of cell proliferation, 
differentiation, migration and survival (Gordon & Blobe, 2008). TGF-β1, 2 and 3 induce 
chondrogenesis and stimulate synthesis of ECM in both chondrocytes and MSCs. They 
trigger the signaling cascade that activates expression of SOX9, a key transcription factor 
necessary for early chondrogenesis. SOX9 activates promoters of genes coding for 
collagen type II, aggrecan and other cartilage-building proteins (Fig 7) (Gaut & Sugaya, 
2015). BMP-2 and -7 together with IGF-1 also promote ECM synthesis. FGF-2 preserves 
chondrogenic potential of monolayer expanded chondrocytes and enhances proliferation 
(Chung & Burdick, 2008).  
 In addition to growth factors, many protocols for chondrogenic differentiation also 
include ascorbic acid and dexamethasone. Ascorbic acid is required for collagen and 
proteoglycan synthesis. It is also shown that stimulates differentiation and proliferation 
of MSCs (Choi et al, 2008). Dexamethasone (DEX) is a synthetic glucocorticoid that 
showed ability to direct regulation of cartilage-specific genes in culture of MSCs. 
Glucocorticoids usually act as inhibitors of chondrocyte cell growth and ECM synthesis, 
but reports are suggesting that specific DEX concentrations seem to have synergistic 
effect with chondrogenic growth factors (especially TGF-β1) and thus contribute to 
chondrogenesis of MSCs (Awad et al, 2003).  
 In natural environment i.e. in the joint, chondrocytes are exposed to reduced 
oxygen tension (6-10% at the surface and only 2% in the deep zone) and elevated 
hydrostatic pressure. Mimicking of these conditions represents a new additional strategy 
for improvement of in vitro cartilage formation (Chung & Burdick, 2008). Studies suggest 
that culturing of MSCs in hypoxic conditions (5% O2) promotes expression of 
chondrogenic transcription factors, including SOX transcription factors, synthesis of ECM 
and collagen type II production (Gaut & Sugaya, 2015). The transcription factor, hypoxia-
inducible factor-Iα (HIF-Iα) is a crucial mediator of this cellular response to hypoxia (Fig 
7) (Kanichai et al, 2008). Chondrocytes in the joint are also exposed to mechanical loading 
and forces which affects their metabolism and enables nutrient and oxygen exchange. 
Several studies confirmed that application of mechanical stimulation in vitro promotes 
differentiation and matrix production. A significant challenge remains to determine the 
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optimal frequency, type and timing of mechanical loading on cultures for cartilage TE 
(Gaut & Sugaya, 2015; Laganà et al, 2008; Vunjak-Novakovic et al, 2002). 
 
 
 
Figure 7. Basic stimuli and signaling pathways modulating mRNA expression of 
chondrogenic genes. Growth factors, hypoxic conditions and mechanical stimulation promote 
production of cartilage-specific proteins while inhibiting pathways that lead to hypertrophy and 
osteogenesis (from Gaut & Sugaya, 2015). 
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2. OBJECTIVE OF THE STUDY 
 
 The primary goal of TE approach is to produce tissue implants that structurally 
and functionally resemble native tissue that needs to be repaired. For successful 
engineering of each tissue, a right combination of cell type, scaffold and inductive signals 
(chemical and physical) must be used.  Poor ability of self-repair, ineffectiveness of 
common treatment options together with the growing problems of obesity and ageing of 
general population, make the articular cartilage an ideal candidate for TE approach. Again, 
the ultimate challenge is to choose the right combination of main TE components in order 
to produce functional cartilage tissue. This research is an attempt of optimization of 
conditions for cartilage tissue engineering. The specific goals of this research are: 
 
 To establish a 3D culture system for cell growth in a self-assembling peptide 
hydrogel RADA  
 To determine and compare chondrogenic potential of three different cell types: 
chondrocytes, human bone marrow stem cells (hBMSCc) and a combination of 
chondrocytes and hBMSCs in 2:1 ratio 
 To demonstrate the effect of oxygen tension on the efficiency of chondrogenic 
differentiation 
 To demonstrate the influence of dexamethasone source (in chondrogenic medium 
or incorporated within the peptide hydrogel scaffold) on chondrogenesis 
 To determine the kinetics of dexamethasone release from the peptide hydrogel 
scaffold 
 
Hypothesis: chondrocytes cultivated in a co-culture with hBMSCs will improve their 
proliferation and chondrogenesis. Hypoxic conditions will enhance efficiency of 
chondrogenesis since oxygen tension in cartilage is naturally low. Dexamethasone source 
will not influence on efficiency of chondrogenesis, but addition of dexamethasone in the 
hydrogel scaffold will make cultivation easier since it does not need to be added in the 
medium.    
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3. MATERIALS AND METHODS  
 
3.1. Isolation of human articular chondrocytes 
 
 Chondrocytes were isolated from articular cartilage of the knee obtained after 
knee surgery performed at clinical hospital „Sveti Duh“ in Zagreb with approval of the 
patient and Ethical comitee. Samples of cartilage tissue were put in the physiological 
solution and kept on ice until isolation. Isolation was performed soon after in the sterile 
conditions. Samples were put in PBS and sliced with sharp sterile scalpel blade as finely 
as possible. Cutting of the sample in the small pieces improves subsequent enzymatic 
digestion of the tissue. Pieces of tissue and PBS were then centifuged for 5 min at 300 g 
and 4 ˚C. Supernatant was removed and 0,08% bacterial colagenase II in DMEM 
(Dulbecco's Modified Eagle's Medium, Lonza) was added. Samples were incubated in 
DMEM/colagenase over night at 37 ˚ C. Once digested, the cellular suspension was strained 
through commercially available cell strainers (BD Falcon, 100 µm pore size) to remove 
large particles and centrifuged at 300 g for 5 min to obtain a cell pellet. Cells were 
resuspended in high-glucose DMEM supplemented with 10% FBS (Gibco), 1% 
penicillin/streptomycin (Lonza) and 1% L-glutamine (100 x GlutaMAX, Gibco) and plated 
into Petri dishes at low cell density. Cells were grown at 37˚C and 5% CO2 with media 
changes every 3 days. When confluence was reached, cells were rinsed with PBS and 
trypsinized with 2 mL of trypsin (0,25% trypsin, Sigma) per each Petri dish to promote 
detachment of cells. After 5 min, trypsin was deactivated with addition of growth medium 
and cell suspension was centrifuged at 300 g for 5 min. Pellet was resuspended in freeze 
medium containing 80% high-glucose DMEM, 10% DMSO (Sigma) and 10% FBS. 
Suspension was transferred in 2 mL cryo-vials, freezed at -80˚C and than transferred in 
liquid nitrogen until use. 
 
3.2. Expansion of human articular chondrocytes 
 
 Tube containing chondrocytes in freeze medium was removed from liquid 
nitrogen and thawed in a 37 ˚C water bath. Thawing is a stressful process for cells and 
needs to be performed as quickly as possible to ensure viability and functionality of cells. 
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After thawing, cell suspension was transferred in high-glucose DMEM (containing 10% 
FBS, 1% penicillin/streptomycin and 1% L-glutamine) and centrifuged for 7 min at 300 g 
and 4 ˚C in order to remove DMSO. Supernatant was removed while cells were 
resuspended in 10 mL of DMEM per large Petri dish and put in incubator at 37 ˚C, 5% CO2. 
After 24 h chondrocytes were observed under inverted light microscope. They were 
attached to the plastic surface of the Petri dish and medium was changed. Confluence was 
reached 3 days after and chondrocytes needed to be transferred to another Petri dish in 
a lower cell density in order to keep their ability of dividing and growth. Each transfer of 
cells to the new dishes in a lower cell density is called a passage. Cells were passaged until 
sufficient number of cells was produced. Cells were washed with PBS, trypsinized with 2 
mL of trypsin per each dish and put in an incubator. After 5 min, trypsin was inactivated 
with addition of 4 mL of DMEM. Cells from each Petri dish were transferred in two new 
dishes. Medium was added up to a volume of 10 mL per dish. Medium change was 
performed 3 days after. Therefore, chondrocytes were passaged only once. 
 
3.3. Expansion of human bone marrow mesenchymal stem cells 
(hBMSCs) 
 
 Tube with human bone marrow derived mesenchymal stem cells (hBMSCs) was 
removed from liquid nitrogen and thawed in water bath. Cells were put in medium and 
centrifuged for 7 min at 300 g and 4˚C to remove DMSO. Pellet was resuspended in 4 mL 
of low-glucose DMEM (Lonza) containing 10% FBS, 1% L-glutamine, 1% 
penicillin/streptomycin with addition of a growth factor FGF-2 (Gibco) in a concentration 
of 10 ng/mL. This medium keeps hBMSCs in an undifferentiated state and contributes to 
their proliferation. Cell suspension was transferred in cell culture flask (BD Falcon, 250 
mL, polystyrene) and filled with medium up to 14 mL. Cells were put in incubator at 37 
˚C, 5% CO2. After 24 h mesenchymal stem cells were attached, while certain amount of 
hematopoietic stem cells that were isolated from bone marrow together with 
mesenchymal stem cells remained floating in the medium. Media exchange thus removes 
hematopoietic and leaves only mesenchymal stem cells. Cells were washed with PBS and 
14 mL of new media was added. Cells were passaged 2 times with media exchange every 
2 days. 
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3.4. Chondrogenic differentiation 
 
3.4.1. Differentiation medium 
 
 Chondrogenic medium was prepared according to protocol developed by Center 
for Advanced Orthopaedic Studies, Beth Israel Deaconess Medical Center, Harvard 
Medical School, optimized for chondrogenesis of hBMSCs in pellet culture. 
Medium was composed of high-glucose DMEM supplemented with 10% FBS and 1% 
penicillin/strepromycin with addition of following components: 
  
 L-proline in a final concentration of 40 µg/mL (Sigma) 
 Ascorbic acid-2-phosphate in a final concentration of 50 µg/mL (Santa Cruz) 
 1 x Insulin-transfferin-selenium (ITS) (Sigma) 
 TGFβ-1 in a final concentration of 10 ng/mL (Abcam) 
 
 Two different media were prepared. One contained L-proline, ascorbic acid-2-
phosphate, ITS and TGFβ-1 and in the second one, beside these components 
dexamethasone was added in a final concentration of 10-7 M (Sigma, diluted in 100% 
ethanol). 
 
3.4.2. Preparation of cells 
 
 One flask with hBMSC containing approximately 106 cells was harvested. Cells 
were washed with PBS and trypsinized with addition of 2 mL of trypsin and put in an 
incubator at 37 ˚C for 5 min. Trypsin was inactivated with addition of 10 mL of DMEM. 
Cells were centrifuged for 5 min at 300 g and 4 ˚C. Cell pellet is resuspended in 10% 
sucrose and centrifuged again for 5 min at 300g and 4 ˚C. Cell pellet is resuspended in 1 
mL of 10% sucrose to obtain a cellular suspension with a concentration of 106 cells/mL. 
Cellular suspension was put on ice until mixing with peptide hydrogel scaffold. 
 Two large Petri dishes with chondrocytes containing approximately 106 cells each 
were harvested. Cells were washed with PBS, trypsinized with 2 mL of trypsin and put in 
an incubator for 5 min. In each dish 4 mL of DMEM were added for trypsin inactivation. 
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Content of both dishes was transferred in the same centrifuge tube (ISOLAB, 15 mL) and 
centrifuged for 5 min at 300 g and 4˚C. Cell pellet was resuspended in 10% sucrose and 
centrifuged again. Cell pellet was resuspended in 2 mL of 10% sucrose to achieve a final 
concentration of 106 cells/mL. Cells were put on ice until required. 
 Suspension containing a combination of chondrocytes and hBMSCs in 2:1 ratio was 
prepared as a mixture of corresponding volumes of previously prepared suspensions of 
chondrocytes and hBMSCs in a 10% sucrose. Minimal required volume of this suspension 
is estimated based on the number of cell inserts which should contain combination of 
chondrocytes and hBMSCs. Suspension is put on ice until mixing with peptide hydrogel. 
 
3.4.3. Peptide hydrogel scaffold with and without dexamethasone 
 
 Commercially available Corning®PuraMatrixTM Peptide Hydrogel is used as a 
scaffold (Fig 8). It is a synthetic matrix, used to create three dimensional 
microenvironments for a variety of cell culture experiments. It is a member of RADA 16 
family, consisted of 1% of standard amino acids and 99% of water. Under physiological 
conditions peptides self-assemble in a 3D hydrogel (Fig 8).   
 
                                          
Figure 8.  Gelation process of PuraMatrixTM peptide hydrogel. When PuraMatrixTM Peptide 
Hydrogel is exposed to physiological salt conditions, the peptide self-assembles into hydrogel 
(from e to h) (from: www.linevikingsson.blogg.se). 
 
  Prior to use, a 500 µL aliquot of RADA was vortexed and then mixed with 500 µl of 
20% sucrose to generate 2x concentration of RADA in 10% sucrose (addition of sucrose 
to RADA hydrogel and previously to cells is necessary in order to protect cells until the pH 
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is normalized by equilibration with tissue culture media during 3D culture 
establishment).  
 Two types of peptide hydrogel scaffolds were prepared: one without 
dexamethasone and other with dexamethasone. Hydrogel without dexamethasone is 
prepared by aliqoting 50 µL of RADA/sucrose mixture in 1,5 mL tubes. Hydrogel scaffolds 
with dexamethasone were prepared in 1,5 mL tubes by mixing of 48,5 µl RADA/sucrose 
suspension with 1,5 µl of dexamethasone (Sigma, 10-3 M stock solution). The final 
concentration of dexamethasone in hydrogel scaffold was 1,5 x 10-5 M. 
 
3.4.4. Establishment of three-dimensional cell culture 
 
 Three dimensional stationary cell culture was established by encapsulation of cells 
in the peptide hydrogel placed in cell culture inserts (Falcon 0,4 µm pore size PET track-
etched membrane 24 well format cell culture inserts) (Fig 9) inserted in a corresponding 
24 well plate. Two such plates were needed, one for growth in normoxic (20% O2) and 
other in hypoxic conditions (5% O2). 
 
 
Figure 9. Cell culture inserts with a corresponding 24 well plate. Pores at the bottom 
membrane of cell inserts allow medium flow while flanges on the insert rim facilitate handling 
(downloaded from www.biolab.com.). 
 
 
  Each plate contained two groups of samples: in one group dexamethasone was 
added only in the chondrogenic medium and in the other group it was embedded in a 
hydrogel scaffold and thus was not added in the medium. Each sample group involved 
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duplicates of hBMSCs, chondrocytes and combination of chondrocytes and hBMSCs in 2:1 
ratio (Fig 10). 
 
 
Figure 10. Scheme of types and arrangement of samples on 24 well plates. 
 
 
 Each plate is prepared according to following protocol: desired number of cell 
culture inserts was placed in wells. Wells were filled by carefull pipetting of 200 µL of 
corresponding chondrogenic medium down the side of the well, between the insert and 
the well. Inserts were filled with a mixture of previously prepared cells and RADA in 
sucrose. The final volume of RADA/sucrose and cell/sucrose mixture in each insert was 
100 µL. This mixture is prepared by quick, but gentle pippeting 50 µL of corresponding 
cell/10% sucrose suspension in 50 µL of corresponding RADA/20% sucrose preparation. 
Therefore, the final concentration of RADA was 0,25%. Upon preparing, each RADA/cell 
mixture is gently resuspended and quickly pipetted into the center of the insert. In the 
moment when all inserts were filled with RADA/cell mixture, in each insert 2 x 200 µL of 
corresponding medium was added. It was important to work as quickly as possible to 
minimize the amount of time that cells were in contact with RADA prior to addition of 
media since RADA exhibits low pH. Salts from the medium triggered self-assembly of 3D 
hydrogel. To complete the gelation of hydrogel, both plates were incubated for 1 h in an 
incubator at 37 ˚C.  After 1 h, medium was changed. Medium in the wells below inserts 
was removed with a vacuum aspirator. From cell inserts 200 µL of medium was removed. 
Both, in the wells below inserts and in cell inserts, 200 µL of medium was added. Plates 
were returned to the incubator for 1 h. After 1 h, second medium change was performed 
in the same way, but this time in the wells below inserts, 900 µL of medium was added. 
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One plate is placed in a standard cell culture incubator in normoxic conditions and other 
in hypoxic chamber. Medium was changed every 2-3 days during 19 days.  
 
 
3.5. Total RNA isolation 
 
 On the 19. day samples were taken out of the inserts. Medium from wells was 
removed with a vacuum aspirator while 200 µL was carefully removed from inserts with 
a pipettor. Scaffolds were washed with PBS which was added both in the inserts and in 
the wells. After removing PBS, the entire content of each insert is taken out with a sterile 
spatula and placed in 500 µL of TRIzol® reagent (Invitrogen). Isolation of total RNA is 
performed according to manufacturer’s instructions. In order to lyse cells, samples were 
homogenized with steel beads for 4 min at 15 Hz followed by addition of 100 µL of 
chloroform. Samples were thoroughly vortexed and centrifuged for 15 min at 12 000g and 
4 ˚C. Upper aqueous phase, where RNA is located, is transferred to a new tube and 500 µL 
of isopropanol is added. Samples were vortexed and incubated at -20 ˚C over night. Next 
day samples were thawed and then centrifuged for 4 min at 12 000g and 4 ˚C. Pellet was 
preserved, mixed with 1 mL of 80% ethanol and centrifuged for 5 min at 20 000g and 4 
˚C. Ethanol was removed. Pellets of RNA were air dried and diluted in 30 µL of DEPC water 
in thermoblock at 55 ˚C for 5 min with mixing. RNA concentration is measured using 
NanoDrop 1000 spectrophotometer (ThermoScientific). Samples were stored at -80 ˚C. 
 
3.6. Gene expression analysis by quantitative real-time polymerase 
chain reaction (qPCR) 
 
 Quantitative real-time polymerase chain reaction (qPCR) is a highly sensitive 
method used for quantification of a specific nucleic acid sequence (DNA, RNA or cDNA) 
with the detection of PCR product in real time. In this research, qPCR method is used to 
compare expression levels of cartilage marker genes between samples in order to 
determine which cell type and culture conditions are most beneficial for chondrogenesis 
and application in cartilage TE. Expression levels of SOX9 (which codes for cartilage 
specific transcription factor) and ACAN (aggrecan core protein) were evaluated. 
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 Prior to qPCR, total cell RNA was treated with RNase free DNase I enzyme 
(BioLabs) according to manufacturer’s instructions in order to remove possible 
contaminations with genomic DNA. Purified RNA was then reverse transcribed in 
complementary DNA (cDNA). The reverse transcription was performed in 20 µL reaction 
mixture containing 9,2 µL of DNase treated RNA sample, 4 µL of 25 mM MgCl2 
(Fermentas), 2 µL of 10x Buffer without MgCl2 (Applied Biosystems), 2 µL of 10 mM 
dNTPs (Bio Basic Canada), 0,8 µL of Ribolock RNase inhibitor (Thermo Scientific, 40 
U/µL), 1 µL of random hexamers (Invitrogen) and 1 µL of MuLV reverse transcriptase 
(Applied Biosystems). Reaction mixtures were incubated 10 min at room temperature, 1 
h at 42 ˚C, 5 min at 99 ˚C  and 5 min at 5 ˚C.  After RT, each sample was diluted with miliQ 
water to obtain cDNA in a final concentration of 20 ng/µL.  
 Relative expression of SOX9 and ACAN genes was determined using commercially 
available primers (Sigma) by quantitative real-time PCR performed on 7500 Fast Real-
Time PCR System machine  (Applied Biosystems). Endogenous control was β-actin 
housekeeping gene, constitutively expressed in all tissues and cells. Each reaction was 
performed in a duplicate on a 96-well plate (ABI PRISM Optical 96-Well Plate, Applied 
Biosystems). Each real-time PCR reaction mixture contained 40 ng of sample cDNA. The 
detection system was based on SYBR Green I flourescent dye (Applied Biosystems) 
present in qPCR master mix, which binds to double-stranded DNA. As the PCR progresses, 
more PCR product is created. An increase in flourescence intensity is proportional to the 
amount of PCR product produced. After real-time PCR reaction, results were analysed 
using 7500 System Software v2.0.6 and Microsoft Office Excel. For each sample a treshold 
cycle or Ct value was determined. A Ct value is a cycle number at which the fluorescent 
signal of the reaction crosses the treshold. A lower Ct value is indicative of higher starting 
amount of the target in the sample (and vice versa). Ct values were normalized to a Ct 
value of endogenous control. Fold changes in gene expression were calculated using ΔΔCt 
method. Since qPCR reactions for samples from both hypoxic and normoxic conditions 
could not be performed in the same run (on the same 96-well plate), results for samples 
grown in hypoxic conditions were calibrated to the same reference sample to which 
results from normoxia were calibrated. On this way, results from both runs could be 
compared. RQ value for each sample is calculated as a mean value of duplicates. Relative 
expression levels between samples were compared using  Student’s t test. 
 
 
 
 
28 
 
3.7. Measuring of dexamethasone release from peptide hydrogel 
scaffold 
 
 Since the concentration of dexamethasone could not be measured in chondrogenic 
medium and was too low for detection, another system was established where PBS 
instead of medium was used. Concentration of dexametasone in PBS can be measured 
more accurately compared to medium. Therefore, two additional peptide hydrogel 
scaffolds in cell inserts were made.  
One contained 100 µL of peptide hydrogel scaffold obtained by mixing 42,5 µL of RADA 
and equal volume of 20% sucrose with 15 µL of dexamethasone (10-2 M stock solution). 
The final concentration of dexamethasone in the scaffold was 1,5 x 10-3 M. Second insert 
contained only mixture of 50 µL of RADA and 50 µL of 20% sucrose, without 
dexamethasone. These inserts and wells were filled with only 700 µL of PBS (400 µL in 
wells and 300 µL in inserts) compared to the 1300 µL of medium which cell culture inserts 
from the experiment contained. Also, higher concentration of dexamethasone was 
incorporated within this peptide hydrogel. Smaller volume of PBS and a higher 
concentration of embbeded dexamethasone resulted in a higher concentration of released 
dexamethasone which is easier to measure. Every 24 h 2 µL of PBS were taken from 
inserts and the absorbance was measured at 242 nm using NanoDrop 1000 (Thermo 
Scientific). Each measurement was repeated 3 x and mean value is calculated. Hydrogel 
scaffold without dexamethasone was used as a control of hydrogel degradation since 
absorbance of hydrogel peptide and dexamethasone overlap at 242 nm. The molar 
extinction coefficient of dexamethasone in PBS at 242 nm is 72 500 M-1cm-1 and it was 
used for calculation of dexamethasone concentration. Concentration was calculated from 
Lambert-Beer law, where A=εlc.   
 Additionally, 10 µL of dexamethasone (10-2 M stock solution) were put in 990 µL 
of PBS in a 1,5 mL plastic tube, so the final concentration of dexamethasone was 10-4 M. 
This served as a control used to monitor stability of dexamethasone in PBS over time. 
Every 24 h absorbance was measured at 242 nm. 
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4. RESULTS 
 
4.1. Morphology of cartilage tissue after chondrogenic dfferentiation 
 
After 19 days of chondrogenic differentiation experiment, morphology of the formed 
tissue was observed under inverted light microscope (Fig 11). Hydrogel was taken out 
from the inserts and put in TRIzol reagent for RNA isolation afterwards (Fig 12). 
 
 
   
 
                   
 
 
 
 
 
 
Figure 11.  Morphology of cartilage tissue in the peptide hydrogel scaffold after 19 days of 
chondrogenic differentiation. Combination of chondrocytes and hBMSCs grown in hypoxic 
conditions with dexamethasone incorporated within the peptide hydrogel scaffold. Photograph 
taken under inverted light microscope, 50x. 
 
                                             
 
Figure 12. Appearance of cell inserts after 19 days (left). Transparent layer of peptide 
hydrogel is visible at the bottom of the insert; the rest is chondrogenic medium. Peptide 
hydrogel taken out of the cell insert (right). 
 
 
Peptide 
hydrogel 
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4.2. Kinetics of dexamethasone release from the peptide hydrogel 
scaffold 
 
 Dexamethasone was mixed with the peptide hydrogel and became entrapped 
within during the gelation process. As hydrogel degraded, dexamethasone released in PBS 
and its absorbance was measured with spectrophotometer at 242 nm.  In the first 24 h, 
there was a rapid increase of dexamethasone concentration, when 30% of dexamethasone 
was released from the peptide hydrogel. From day 2 to day 8, concentration did not 
change considerably, while from day 8 to day 12 additional 30% of dexamethasone was 
released. The majority of hydrogel was degraded around day 12 since after day 12 
dexamethasone concentration no longer changed (Fig 13). 
 
 
 
Figure 13.  Cumulative release of dexamethasone from peptide hydrogel scaffold in cell 
insert. The initial concentration of dexamethasone in the peptide hydrogel was 1,5 x10-3 M. 
 
 These results were used for approximation of dexamethasone release from the 
peptide hydrogel scaffold in the 3D system established for cartilage TE. The initial 
concentration of dexamethasone in these scaffolds was 1,5 x10-5 M. 
The volume of chondrogenic medium was 1300 µL.  Medium changes were performed 
every 2-3 days in the period of 19 days (Fig 14). 
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Figure 14. Concentration of dexamethasone in the chondrogenic medium in cell inserts 
where dexamethasone was incorporated within the peptide hydrogel (1,5 x 10-5M).  
Sudden decreases of concentration to 0 (vertical lines) represent the time when chondrogenic 
medium was changed. 
 
 
 
 In the first 2 days, dexamethasone concentration in chondrogenic medium was 
between 1,75 x 10-7 M and 3,55 x 10-7 M. After first medium change, from day 2 to day 6, 
concentration was very low.  At day 7 and 9, concentration was around 6 x 10-8 M. From 
day 9 to day 12, concentration considerably increased and cells were exposed to a 
dexamethasone concentration in the range from 1-2 x 10-7 M. After medium change at day 
12, concentration remained significantly low until the end chondrogenic differentiation 
experiment. 
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4.3. Expression of cartilage marker genes  
 
 Relative expression of cartilage marker genes SOX9 and ACAN was determined at 
mRNA level using qPCR. RNAs isolated from bone and native cartilage were used as a 
negative and positive control, respectively. Relative expression of SOX9 and ACAN in all 
samples was calibrated to the same reference sample- combination of chondrocytes and 
hBMSCs grown in normoxic conditions with dexamethasone added in the chondrogenic 
medium.  The results showed that chondrogenic differentiation of various cell types was 
not equally successful. Chondrocytes turned to have the highest chondrogenic potential 
among used cell types (Fig 15). Relative expression of SOX9 and ACAN in hBMSCs 
compared to other cell types was extremely low (Fig 15, 16, 17 and 18). Therefore, 
hBMSCs showed the lowest chondrogenic potential. Considering the influence of oxygen 
tension on chondrogenic differentiation, only in the case of chondrocytes there was a 
statistically significant difference, where hypoxic conditions proved to be more beneficial 
for chondrogenesis than normoxic conditions (Fig 15). Dexamethasone source, in 
chondrogenic medium or peptide hydrogel scaffold, did not significantly influence on 
differences in SOX9 and ACAN expression levels between samples. 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
 
Figure 15. Relative expression of SOX9 gene in samples of chondrocytes, hBMSCs and their 
combination grown in hypoxic (H) and normoxic (N) conditions.  Dexamethasone was 
added in the chondrogenic medium. *p<0,05 
 
 
 
 
Figure 16.  Relative expression of SOX9 gene in samples of chondrocytes, hBMSCs and 
their combination grown in hypoxic (H) and normoxic (N) conditions. Dexamethasone 
was incorporated within the peptide hydrogel scaffold. 
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Figure 17.  Relative expression of ACAN gene in samples of chondrocytes, hBMSCs and 
their combination grown in hypoxic (H) and normoxic (N) conditions. Dexamethasone 
was added in the chondrogenic medium. 
 
 
 
Figure 18. Relative expression of ACAN gene in samples of chondrocytes, hBMSCs and 
their combination grown in hypoxic (H) and normoxic (N) conditions. Dexamethasone 
was incorporated within the peptide hydrogel scaffold. 
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5. DISCUSSION 
 
 Articular cartilage is a tissue with very limited ability for self-repair. This is mostly 
attributed to the absence of blood vessels, nerves and undifferentiated progenitor cells 
that can promote repair process. Common methods for treatment of cartilage defects and 
injuries are not entirely effective, resulting in a formation of tissue which is structurally 
and functionally inferior to native articular cartilage and often involve invasive 
procedures that require long period of rehabilitation. With an aging population and 
growing problem of obesity, it is assumed that cartilage injuries and defects will become 
major health, social and economic problem in the near future. Tissue engineering as a new 
and revolutionary field of medicine could provide improvements and solutions in 
treatment and repair of many damaged tissues and organs, including articular cartilage. 
Tissue engineering combines cells, 3D scaffolds and appropriate inductive signals 
(chemical, mechanical, physical) to produce a functional tissue construct that can be 
implanted in a patient in order to restore or improve structure and function of 
damaged/injured tissue. This approach opens a possibility of using patient’s own cells to 
overcome problems with transplant rejection or disease transmission. The main 
challenge of tissue engineering is to choose a right combination of cells, scaffold, chemical 
signals and conditions that will finally result in a formation of desired tissue. This is also 
a great challenge in cartilage tissue engineering. 
  In this respect, the aim of this study was to optimize conditions for 3D in vitro 
chondrogenesis. The optimization method included: i) cell type, ii) oxygen tension and iii) 
source of dexamethasone. Chondrogenic potential of three different cell types was 
analyzed: chondrocytes, human bone marrow mesenchymal stem cells (hBMSCs) and co-
culture of chondrocytes and hBMSCs in 2:1 ratio. Cells were grown in a 3D system in cell 
inserts, encapsulated in a self-assembling peptide hydrogel (RADA)4 , a new class of 
scaffold widely researched for the purposes of tissue engineering. Cells were grown in a 
chondrogenic medium for 19 days. One of the chondrogenic medium components, 
dexamethasone, was added in a chondrogenic medium or was incorporated with cells 
within a peptide hydrogel scaffold. In order to explore the effects of oxygen tension on 
chondrogenic differentiation, cells were grown in either hypoxic (5% O2) or normoxic 
(20% O2) conditions. After 19 days, samples were harvested and expression of two 
cartilage marker genes SOX9 and ACAN was analyzed using qPCR. Additionally, kinetics of 
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dexamethasone release from the peptide hydrogel was explored in order to determine 
dexamethasone concentration to which cells were exposed during period of 19 days. 
 
 According to the results of gene expression analysis, chondrocytes grown in 
hypoxic conditions showed the highest chondrogenic potential among used cell types. 
Before chondrogenic differentiation experiment, chondrocytes were expanded in a 
monolayer culture in order to obtain sufficient cell number for seeding in a peptide 
hydrogel. Several studies showed extensive changes in gene expression in chondrocytes 
upon passaging. This process mainly affects collagen II production and genes involved in 
signaling networks responsible for maintenance of chondrocyte’s phenotype. 
Dedifferentiation represents the main obstacle for cartilage tissue engineering using 
chondrocytes as a cell source (Ma et al, 2013; Schnabel et al, 2002). However, this process 
is reversible. Caron et al (2012) investigated the effects of 2D and 3D culture system on 
redifferentiation of passaged chondrocytes. Three-dimensional cultures expressed 
cartilage specific genes for collagen type II, aggrecan core protein and SOX9 transcription 
factor, while 2D did not. Furthermore, a reduced oxygen tension also proved to promote 
redifferentiation of passaged chondrocytes. Chondrocytes grown in hypoxic conditions 
(2-5% O2) showed enhanced production of ECM components (collagen type II, aggrecan, 
GAGs) and decreased production of collagen type I, collagen type X, matrix 
metalloproteinases and aggrecanases (Markway et al, 2013; Coyle et al, 2009; Murphy & 
Sambanis, 2004).  Therefore, based on these studies and obtained results, it can be 
assumed that RADA encapsulation and reduced oxygen tension helped restore key 
differentiated phenotypic markers of passaged chondrocytes. 
 
 Human bone marrow mesenchymal stem cells showed the lowest chondrogenic 
potential in this study. Expression levels of SOX9 and ACAN genes were extremely low 
regardless of oxygen tension and there was no difference between samples grown in 
normoxia and hypoxia. This result is inconsistent with most of the studies involving 
hBMSCs chondrogenesis where oxygen tension proved to be important promoting factor.  
In most of the studies, hypoxia proved to enhance proliferation and chondrogenic 
differentiation of hBMSCs, which was also expected here (Ren et al, 2006; Robins et al, 
2005). Grayson et al (2006) reported an increase in osteogenic and adipogenic 
differentiation of 3D cultures of bone marrow derived mesenchymal stem cells under 
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hypoxia. Compared to this study, in Grayson’s experiment cells isolated from bone 
marrow were both expanded and differentiated in 3D architecture under hypoxic 
conditions. In this study, hypoxic conditions and 3D culture system were applied only 
during the differentiation experiment. Cicione et al (2013) also applied hypoxia only 
during in vitro directed differentiation of hBMSCs. In their study, chondrogenic 
differentiation also was absent in severe hypoxic conditions. As known from the 
literature, hypoxia can act as a stimulus altering cellular metabolism through the activity 
of hypoxia-inducible factor-1 α (HIF-1α) (Semenza, 2001). It is shown that HIF-1α 
downregulates mitochondrial oxygen consumption and upregulates key markers of stem 
cells like Oct-4 (D’Ippolito et al, 2006). Cicione and colleagues hypothesized that 
relationship between HIF-1α, cell proliferation and stem cell markers could explain the 
absence of stem cell differentiation under hypoxic conditions. Dos Santos et al (2010) 
reported that hypoxia promotes cell proliferation and expansion. During proliferation, the 
majority of the cells undergo cell division and cannot begin the cellular mechanisms 
involved in differentiation. Therefore, expansion of hBMSCs in hypoxia seems to promote 
proliferation and preserve their differentiation capacity (so called ‘stemness’). For further 
optimization of cartilage tissue engineering using hBMSCs, both expansion and in vitro 
differentiation are recommended to be carried out in hypoxic conditions.  
 This, however, does not explain a failure of hMBSCs grown in normoxic conditions 
to undergone chondrogenesis. Expression levels of SOX9 and ACAN were as low as in 
hBMSCs grown in hypoxic conditions.  Xu et al (2008) characterized temporal changes in 
expression of chondrogenic genes and developed a staging scheme for in vitro 
chondrogenic differentiation of hMSCs grown in 3D alginate-gels. Using qRT-PCR, they 
demonstrated a largely characteristic temporal pattern of chondrogenic markers and 
divided the progression of cellular phenotype into four main stages. According to their 
results, SOX9 expression reaches peak level in stage II (days 6-12), while ACAN attains its 
peak levels in stage IV (days 18-24). Therefore, ACAN as a late marker of chondrogenic 
differentiation of hBMSCs, should have high(er) expression level at day 19. But since both 
genes showed negligible expression levels, it brings to conclusion that chondrogenic 
differentiation in hBMSCs grown both in hypoxic and normoxic conditions was not 
induced. 
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 Co-culture of chondrocytes and hBMSCs in 2:1 ratio proved to have higher 
chondrogenic potential than hBMSCs, but lower than chondrocytes. Oxygen tension did 
not significantly influence on chondrogenesis in co-culture, although samples grown in 
normoxia demonstrated higher expression levels of ACAN compared to samples grown in 
hypoxia. Cheng et al (2011) demonstrated that co-culture of rabbit chondrocytes and 
rabbit BMSCs at defined ratios can promote the expression of cartilaginous ECM. They 
determined the 2:1 ratio (chondrocytes:BMSCs) to be optimal since the expression of 
collagen type II and aggrecan in this group on day 21 was higher than in other groups 
containing individually cultured chondrocytes and BMSCs or co-culture of chondrocytes 
and BMSCs in  4:1, 1:1, 1:2 and 1:4 ratio. Neocartilage can develop through co-culturing of 
chondrocytes and hBMSCs even in the absence of biomolecular factors such as serum and 
exogenous growth factors. It is hypothesized that chondrocytes promote chondrogenesis 
of BMSCs via paracrine regulation since they produce and secrete a variety of protein 
molecules including TGF-β, IGF-1, FGF-2, BMP-2, and many other inductive factors that 
still need to be determined (Yang et al, 2012). Using the co-culture approach, Cooke et al 
(2011) demonstrated neocartilage formation without hypertrophy and calcification.  
 Since individually cultured hBMSCs showed much lower chondrogenic potential 
than co-culture, it can be assumed that chondrocytes in the co-culture enhanced 
chondrogenesis of hBMSCs in this study. Co-culturing of chondrocytes and BMSCs is a 
novel and promising approach in cartilage tissue engineering, but requires further 
research and optimization.  
 
  Analysis of kinetics of dexamethasone release from the peptide hydrogel scaffold 
showed that in the first 24 h, 30% of dexamethasone was released. This initial burst is 
most likely caused by i) molecules that were at or near medium-hydrogel interface and 
escaped rapidly into the medium and ii) dexamethasone release that happens faster from 
the larger pores of hydrogel. After 24 h, a plateau value is reached. From day 9 to day 12, 
another significant increase in concentration happened, while after day 12 the majority 
of hydrogel was degraded and another plateau is reached. Until day 15, about 63% of 
dexamethasone was released. Koutsopoulos et al (2009) demonstrated that in hydrogel 
systems drug or protein release rarely reaches 100%. The main reason is physical 
entrapment of molecules in highly entangled nanofiber domains of the hydrogel. Since 
hydrogels are biodegradable, an introduction of hydrogel into a living organism will cause 
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hydrogel to degrade entirely. This process will allow to the rest of the load from peptide 
hydrogel to be released in the surrounding tissue. Therefore, this study shows that self-
assembling peptide hydrogel RADA may be useful as a carrier for therapeutic proteins for 
sustained release applications.   
 Dexamethasone source did not have significant influence on the differences in 
SOX9 and ACAN expression levels between samples in this study. In most studies, 
chondrogenic culture medium is supplemented with 100 nM dexamethasone over a 
multiweek culture period. Approximation of dexamethasone release from peptide 
hydrogel in the medium in which cells were grown showed  that in the first 10 days, from 
day 2 to day 9, and after day 12, dexamethasone concentration was lower than 
recommended for chondrogenic differentiation, and still, expression levels of 
chondrogenic markers in samples where dexamethasone was embedded in the hydrogel 
were not significantly lower than in samples where dexamethasone was added in the 
medium in a constant optimal concentration. This is consistent with some recent studies 
which suggest that even lower concentration of dexamethasone can still induce 
chondrogenesis. Tangtrongsup & Kisiday (2015) compared the influence of 100 nM and 1 
nM dexamethasone on chondrogenesis of equine MSCs encapsulated in agarose. The ECM 
accumulation was not significantly different in 100 nM and 1 nM dexamethasone, 
although it was suppressed by ~40% in dex-free samples. One nanomolar dexamethasone 
however, did not prevent undesired hypertrophic differentiation. Similarly, Enochson et 
al (2012) recommend 50 nM dexamethasone. Tangtrongsup and colleagues also explored 
the effect of timing of exposure to dexamethasone. Early timing of exposure seems not to 
be critical, while sustained exposure of at least one week appears to be necessary to 
maximize ECM accumulation. Shintani & Hunziker (2011) hypothesized that a final effect 
of dexamethasone on MSCs depends on their tissue origin and a nature of used growth 
factors. Therefore the effects of dexamethasone and its role in chondrogenesis need to be 
more explored and explained. 
 
 Although great advances in the field of cartilage tissue engineering were made, an 
ideal protocol regarding cell source, scaffold, biochemical and physical factors is still not 
established. One of the main challenges still remains unsolved: to produce functional 
construct that mimics a complex structure and zonal organization of cartilage. 
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6. CONCLUSION 
 
Based on the obtained results, it can be concluded: 
 
 Chondrocytes under hypoxic conditions have the best potential for cartilagenous 
tissue formation. Hypoxic conditions, 3D system for in vitro differentiation and 
addition of chondrogenic medium can induce redifferentiation of passaged 
chondrocytes.  
 
 Bone marrow-derived mesenchymal stem cells have the lowest chondrogenic 
potential.  
 
 If hypoxic conditions are not available, the combination of chondrocytes and 
hBMSCs in 2:1 ratio is recommended for cartilage formation.  
 
 Source of dexamethasone does not have a significant infleunce on efficiency of in 
vitro chondrogenesis. 
 
 
 
 Kinetics of dexamethasone release from peptide hydrogel RADA follows the 
kinetics of hydrogel degradation over time. Since RADA is biocompatible and 
biodegradable, it may be useful as a carrier for therapeutic proteins and other 
molecules for sustained release applications.  
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